📣 VC round data is live. Check it out!

PharmX Technologies Valuation Multiples

Discover revenue and EBITDA valuation multiples for PharmX Technologies and similar public comparables like Mach7 Technologies, ezCaretech, EUDA Health, Singular Health and more.

PharmX Technologies Overview

About PharmX Technologies

PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.


Founded

1950

HQ

Australia

Employees

109

Financials (FY)

Revenue: $5M
EBITDA: $994K

EV

$55M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

PharmX Technologies Financials

PharmX Technologies reported last fiscal year revenue of $5M and EBITDA of $994K.

In the same fiscal year, PharmX Technologies generated $4M in gross profit, $994K in EBITDA, and had net loss of ($189K).

Revenue (LTM)


PharmX Technologies P&L

In the most recent fiscal year, PharmX Technologies reported revenue of $5M and EBITDA of $994K.

PharmX Technologies is unprofitable as of last fiscal year, with gross margin of 81%, EBITDA margin of 19%, and net margin of (4%).

See analyst estimates for PharmX Technologies
Last FY202320242025202620272028
Revenue$5M$4M$5M$5M
Gross Profit$4M$4M$4M$4M
Gross Margin81%80%81%81%
EBITDA$994K$636K$1M$994K
EBITDA Margin19%14%21%19%
EBIT Margin(19%)(17%)(20%)(19%)
Net Profit($189K)($1M)($728K)($189K)
Net Margin(4%)(23%)(15%)(4%)

Financial data powered by Morningstar, Inc.

PharmX Technologies Stock Performance

PharmX Technologies has current market cap of $57M, and enterprise value of $55M.

Market Cap Evolution


PharmX Technologies' stock price is $0.09.

PharmX Technologies share price decreased by 8.2% in the last 30 days, and increased by 30.0% in the last year.

See more trading valuation data for PharmX Technologies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$55M$57M-7.9%-8.2%8.9%30.0%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

PharmX Technologies Valuation Multiples

PharmX Technologies trades at 10.5x EV/Revenue multiple, and 55.2x EV/EBITDA.

See NTM and 2027E valuation multiples for PharmX Technologies

EV / Revenue (LTM)


PharmX Technologies Financial Valuation Multiples

As of June 4, 2026, PharmX Technologies has market cap of $57M and EV of $55M.

PharmX Technologies has a P/E ratio of (299.8x).

Last FY202320242025202620272028
EV/Revenue10.5x12.3x11.1x10.5x
EV/EBITDA55.2x86.3x54.1x55.2x
EV/EBIT(53.9x)(71.7x)(55.0x)(53.9x)
EV/Gross Profit12.9x15.2x13.7x12.9x
P/En/m(56.1x)(77.9x)n/m
EV/FCF(7.8x)16.6x(18.6x)(7.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified PharmX Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

PharmX Technologies Margins & Growth Rates

In the most recent fiscal year, PharmX Technologies reported gross margin of 81%, EBITDA margin of 19%, and net margin of (4%).

See estimated margins and future growth rates for PharmX Technologies

PharmX Technologies Margins

Last FY20242025202720282029
Gross Margin81%81%81%
EBITDA Margin19%21%19%
EBIT Margin(19%)(20%)(19%)
Net Margin(4%)(15%)(4%)
FCF Margin(135%)(60%)(135%)

PharmX Technologies Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth10%6%
Gross Profit Growth11%6%
EBITDA Growth60%(2%)
EBIT Growth30%2%
Net Profit Growth(28%)(74%)
FCF Growth(190%)139%

Data powered by FactSet, Inc. and Morningstar, Inc.

PharmX Technologies Operational KPIs

PharmX Technologies' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for PharmX Technologies
Last FY202320242025202620272028
Revenue per Employee$0.0M---
Opex per Employee$0.0M---
S&M Expenses to Revenue5%3%4%5%
G&A Expenses to Revenue69%41%55%69%
R&D Expenses to Revenue(4%)(2%)(3%)(4%)
Opex to Revenue101%98%101%101%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

PharmX Technologies Competitors

PharmX Technologies competitors include Mach7 Technologies, ezCaretech, EUDA Health, Singular Health, SMAIO, MeVis, Susmed, 111, Data Horizon and Insung Information.

Most PharmX Technologies public comparables operate across EHR & Practice Management, Healthcare Software, B2B SaaS, HealthTech and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Mach7 Technologies2.5x2.1x(35.6x)(15.7x)
ezCaretech1.3x-20.7x-
EUDA Health7.7x-(25.0x)-
Singular Health288.8x-(9.6x)-
SMAIO5.8x5.1x(60.2x)(63.8x)
MeVis2.4x-11.3x-
Susmed12.7x12.7x(21.8x)-
1110.0x-(0.0x)-

This data is available for Pro users. Sign up to see all PharmX Technologies competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About PharmX Technologies

When was PharmX Technologies founded?PharmX Technologies was founded in 1950.
Where is PharmX Technologies headquartered?PharmX Technologies is headquartered in Australia.
How many employees does PharmX Technologies have?As of today, PharmX Technologies has over 109 employees.
Is PharmX Technologies publicly listed?Yes, PharmX Technologies is a public company listed on Australian Securities Exchange.
What is the stock symbol of PharmX Technologies?PharmX Technologies trades under PHX ticker.
When did PharmX Technologies go public?PharmX Technologies went public in 1973.
Who are competitors of PharmX Technologies?PharmX Technologies main competitors include Mach7 Technologies, ezCaretech, EUDA Health, Singular Health, SMAIO, MeVis, Susmed, 111, Data Horizon, Insung Information.
What is the current market cap of PharmX Technologies?PharmX Technologies' current market cap is $57M.
What is the current revenue of PharmX Technologies?PharmX Technologies' last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of PharmX Technologies?Current revenue multiple of PharmX Technologies is 10.5x.
Is PharmX Technologies profitable?No, PharmX Technologies is not profitable.
How many companies PharmX Technologies has acquired to date?PharmX Technologies hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies PharmX Technologies has invested to date?PharmX Technologies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to PharmX Technologies

Lists including PharmX Technologies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial